Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Thrombosis and Haemostasis|January 12, 2010
Aspirin therapy: an attempt to explain the events of prothrombotic complications after treatment discontinuationChristian Doutremepuich, Omar Aguejouf, Vanessa Desplat, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 19, 2013
Aspirin discontinuation syndromes: clinical implications of basic research studiesChristian Doutremepuich, Omar Aguejouf, Vanessa Desplat, et al.
Pathophysiology of Haemostasis and Thrombosis|November 19, 2005
Platelet aggregation in portal hypertension and its modification by ultra-low doses of aspirinFrancisco X Eizayaga, Omar Aguejouf, Philippe Belon, et al.
Pathophysiology of Haemostasis and Thrombosis|March 12, 2008
Reverse effect of aspirin: is the prothrombotic effect after aspirin discontinuation mediated by cyclooxygenase 2 inhibition?Christian Doutremepuich, Omar Aguejouf, Francisco X Eizayaga, et al.
Cardiovascular & Hematological Disorders Drug Targets|March 31, 2010
Paradoxical thrombotic effects of aspirin: experimental study on 1000 animalsChristian Doutremepuich, Omar Aguejouf, Vanessa Desplat, et al.
Thrombosis|February 1, 2012
Paradoxical effect of aspirinChristian Doutremepuich, Omar Aguejouf, Vanessa Desplat, et al.
Pathophysiology of Haemostasis and Thrombosis|January 19, 2007
Modifications produced by indomethacin and L-NAME in the effect of ultralow-dose aspirin on platelet activity in portal hypertensionFrancisco X Eizayaga, Omar Aguejouf, Vanessa Desplat, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 8, 2008
Prothrombotic and hemorrhagic effects of aspirinOmar Aguejouf, Francisco Eizayaga, Vanessa Desplat, et al.
Thrombosis|December 24, 2011
Thrombotic events associated to aspirin therapyChristian Doutremepuich, Omar Aguejouf, Vanessa Desplat, et al.
World Journal of Gastroenterology|September 19, 2007
Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertensionFrancisco X Eizayaga, Omar Aguejouf, Vanessa Desplat, et al.
Pageof 2